External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

ELCC 2026

March 25 - March 28

Copenhagen, Denmark / Virtual (Hybrid)

esmo.org

We will be contributing to topics related to

Oncology

Add to calendar

Agenda

Medical Materials

11:00 AM

Duration 60mins Copenhagen, Denmark

IMforte: Subsequent Treatment (Tx) Following First-Line Maintenance (1Lm) With Lurbinectedin (Lurbi) + Atezolizumab (Atezo) or Atezo in Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Yuanbin Chen, Luis Paz-Ares, Hossein Borghaei, Martin Reck, Roy S Herbst, Solange Peters, Grzegorz Czyżewicz, Reyes Bernabé Caro, Melissa L Johnson, Nuri Karadurmuş, Christian Grohé, Sofia Baka, Tibor Csőszi, Xiaoyan Wang, Kamalnayan Bhatt, Stefan Faderl, Vilma Graupner, Vaikunth Cuchelkar, Ya-Chen Lin, Stephen V Liu

Oncology | Small Cell Lung Cancer

Notify me

Add to calendar

Duration 61mins Copenhagen, Denmark

Neoadjuvant divarasib shows manageable safety and promising activity in patients with resectable, early-stage, KRAS G12C+ NSCLC: First results from the NAUTIKA1 KRAS G12C+ cohort

Jamie Chaft, Cummings A, Mohindra N, Negrao M, He K, Kim S-Y, Saltos A, Patil T, Shum E, Lammers P, Schulze K, Zhu Q, Schutzman J, Brandao E, Ngiam C, Bara I, Lee J

Oncology | Non-Small Cell Lung Cancer

Notify me

Add to calendar

Coming soon

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.